BioLine RX Ltd (BLRX) — Cash Flow Quality Index
Latest as of March 2025:
-0.51x
BioLine RX Ltd (BLRX) has a Cash Flow Quality Index of -0.51x as of March 2025. Operating cash flow of ILA-2.59 Million is below net income of ILA5.13 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore BLRX cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
-0.51x
Operating CF / Net Income
Operating Cash Flow
ILA-2.59 Million
ILA
Net Income
ILA5.13 Million
ILA
Data as of
Mar 2025
Most recent filing
BioLine RX Ltd Cash Flow Quality Index (2010–2010)
Historical Cash Flow Quality Index for BioLine RX Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see BioLine RX Ltd cash conversion from operations.
Annual Cash Flow Quality Index for BioLine RX Ltd (2010–2010)
Year-by-year earnings quality comparison for BioLine RX Ltd.
| Year | Quality Index | Operating CF (ILA) | Net Income | YoY Change |
|---|---|---|---|---|
| 2010 | 5.47x | ILA11.46 Million | ILA2.10 Million | — |
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.